Clinical Trials

Title: A Humanitarian Device Exemption Use Protocol of TheraSphere For Treatment of Unresectable Primary or Secondary Liver Neoplasia

Department: Oncology

Diagnosis: Gastrointestinal - Liver

Principal Investigator: Joseph A Ronsivalle, DO

Sponsors: BTG

Title: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS-986165 in Subjects with Moderate-to-Severe Crohn's Disease

Department: Gastroenterology

Diagnosis: Gastrointestinal - Crohn's

Principal Investigator: Michael J Georgetson, MD

• Matthew Lincoln, DO
• Thomas J McDonald, MD
• Ukorn Srivatana, MD
• Debra L Moore, CRNP, MSN, FNP-BC

Sponsors: BMS

Title: A011202: A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy

Department: Oncology

Diagnosis: Breast

Principal Investigator: Thomas J Gergel, MD

Sponsors: ALLIANCE

Title: A011502, A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for Node Positive HER2 Negative Breast Cancer: The ABC Trial

Department: Oncology

Diagnosis: Breast

Principal Investigator: Philip A Lowry, MD

Sponsors: ALLIANCE

Title: A021502: Randomized Trial of Standard Chemotherapy Alone or Combined with Atezolizumab as Adjuvant Therapy for Patients with Stage III Colon Cancer and Deficient DNA Mismatch Repair

Department: Oncology

Diagnosis: Gastrointestinal - Colon-Rectal

Principal Investigator: Joyson Poulose, MD

Sponsors: ALLIANCE

Title: A021703: Randomized Double-Blind Phase III Trial of Vitamin D3 Supplementation in Patients With Previously Untreated Metastatic Colorectal Cancer (SOLARIS)

Department: Oncology

Diagnosis: Gastrointestinal - Colon-Rectal

Principal Investigator: Philip A Lowry, MD

Sponsors: ALLIANCE

Title: A031704: PD-Inhibitor (Nivolumab) and Ipilimumab Followed by Nivolumab vs. VEGF TKI Cabozantinib With Nivolumab: A Phase III Trial in Metastatic Untreated Renal Cell Cancer [PDIGREE]

Department: Oncology

Diagnosis: Genito-urinary - Renal

Principal Investigator: Philip A Lowry, MD

Sponsors: ALLIANCE

Title: A071801: Phase III Trial of Post-Surgical Single Fraction Stereotactic Radiosurgery (SRS) Compared with Fractionated SRS (FSRS) for Resected Metastatic Brain Disease

Department: Oncology

Diagnosis: Brain

Principal Investigator: Thomas J Gergel, MD

Sponsors: ALLIANCE

Title: A081105, Randomized Study of Erlotinib or Observation in Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC)

Department: Oncology

Diagnosis: Lung- Non-Small Cell

Principal Investigator: Philip A Lowry, MD

Sponsors: ALLIANCE

Title: A221505, Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer

Department: Oncology

Diagnosis: Breast

Principal Investigator: Thomas J Gergel, MD

Sponsors: ALLIANCE